Integrative Management of Anorectal Malignancies to Optimize Patient Outcomes with Sharon Gurm, ND, FABNO

$60.00

1.5 CE (.25 rx)

Learning Objectives:

  • Identify the key drivers of malignant anorectal and anal pathology

  • Understand the presenting features, diagnosis and standard of care treatment for anorectal and anal malignancies

  • Know the current evidence supporting complementary therapies in the setting of primary treatment and recurrence prevention of anorectal and anal malignancies

  • Learn innovative strategies to improve compete response in the neoadjuvant setting to avoid surgery or improve surgical outcomes and achieve durable remission (recurrence prevention).

  • Identify the ideal candidates for the PDT-HT approach

Add To Cart

1.5 CE (.25 rx)

Learning Objectives:

  • Identify the key drivers of malignant anorectal and anal pathology

  • Understand the presenting features, diagnosis and standard of care treatment for anorectal and anal malignancies

  • Know the current evidence supporting complementary therapies in the setting of primary treatment and recurrence prevention of anorectal and anal malignancies

  • Learn innovative strategies to improve compete response in the neoadjuvant setting to avoid surgery or improve surgical outcomes and achieve durable remission (recurrence prevention).

  • Identify the ideal candidates for the PDT-HT approach

1.5 CE (.25 rx)

Learning Objectives:

  • Identify the key drivers of malignant anorectal and anal pathology

  • Understand the presenting features, diagnosis and standard of care treatment for anorectal and anal malignancies

  • Know the current evidence supporting complementary therapies in the setting of primary treatment and recurrence prevention of anorectal and anal malignancies

  • Learn innovative strategies to improve compete response in the neoadjuvant setting to avoid surgery or improve surgical outcomes and achieve durable remission (recurrence prevention).

  • Identify the ideal candidates for the PDT-HT approach